RUA Life Sciences plc (AIM:RUA)

RUA Life Sciences Revenue

RUA Life Sciences had revenue of 2.75M GBP in the half year ending March 31, 2026, with 80.25% growth. This brings the company's total for the last twelve months to 4.62M, up 3.54% year-over-year. In the fiscal year ending September 30, 2025, RUA Life Sciences had annual revenue of 4.46M with 8.42% growth. That makes RUA Life Sciences the 39,277th largest company in the world by revenue and 759th in the United Kingdom.

• Revenue (ttm): 4.62M
• Revenue Growth: +3.54%
• P/S Ratio: 3.44
• Revenue / Employee: 78.26K
• Employees: 59
• Market Cap: 15.89M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Contract Manufacturing 3.84M 86.1%
• Biomaterials 609.33K 13.7%
• Vascular 10.67K 0.2%

By Geography

Chart

• North America 3.60M 80.7%
• Europe 782.00K 17.5%
• Middle East 54.00K 1.2%
• Asia Pacific 24.67K 0.6%
• Africa 1.33K 0.0%

Fiscal year ended Sep 30, 2025 See the full RUA Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	4.46M	346.34K	8.42%
Mar 31, 2025	4.11M	1.92M	87.72%
Mar 31, 2024	2.19M	12.00K	0.55%
Mar 31, 2023	2.18M	554.00K	34.09%
Mar 31, 2022	1.63M	97.00K	6.35%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 2, 2026

Data Sources Report a data error